Nile Thompson is the Vice President of Commercialization at Helio Genomics, where he leads the national strategy for the HelioLiver test for early liver cancer detection. A former clinical lab CEO and a Morehouse College attendee, he specializes in translating novel diagnostics into clinical adoption and securing payer access.
He co-founded two prior laboratories and, during the pandemic, one of his labs administered between 4, 000 and 12, 000 COVID-19 tests per day.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.